These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33229892)

  • 1. Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats.
    Douton JE; Augusto C; Stoltzfus B; Carkaci-Salli N; Vrana KE; Grigson PS
    Behav Pharmacol; 2021 Jun; 32(4):265-277. PubMed ID: 33229892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats.
    Urbanik LA; Acharya NK; Grigson PS
    Brain Res Bull; 2022 Oct; 189():155-162. PubMed ID: 36031011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats.
    Hernandez NS; O'Donovan B; Ortinski PI; Schmidt HD
    Addict Biol; 2019 Mar; 24(2):170-181. PubMed ID: 29226617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats.
    Evans B; Stoltzfus B; Acharya N; Nyland JE; Arnold AC; Freet CS; Bunce SC; Grigson PS
    Brain Res Bull; 2022 Oct; 189():163-173. PubMed ID: 36038016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naïve male mice.
    Vestlund J; Jerlhag E
    Horm Behav; 2020 Aug; 124():104778. PubMed ID: 32450068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 receptor agonist, liraglutide, reduces heroin self-administration and drug-induced reinstatement of heroin-seeking behaviour in rats.
    Douton JE; Horvath N; Mills-Huffnagle S; Nyland JE; Hajnal A; Grigson PS
    Addict Biol; 2022 Mar; 27(2):e13117. PubMed ID: 34802173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala.
    Alvarez-Jaimes L; Polis I; Parsons LH
    Neuropsychopharmacology; 2008 Sep; 33(10):2483-93. PubMed ID: 18059440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues.
    Zhou W; Liu H; Zhang F; Tang S; Zhu H; Lai M; Kalivas PW
    Neuroscience; 2007 Feb; 144(4):1209-18. PubMed ID: 17184925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues.
    Bossert JM; Poles GC; Wihbey KA; Koya E; Shaham Y
    J Neurosci; 2007 Nov; 27(46):12655-63. PubMed ID: 18003845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
    Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
    Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats.
    Hernandez NS; Ige KY; Mietlicki-Baase EG; Molina-Castro GC; Turner CA; Hayes MR; Schmidt HD
    Neuropsychopharmacology; 2018 Sep; 43(10):2000-2008. PubMed ID: 29497166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dopamine D(1)-family receptors in dorsolateral striatum in context-induced reinstatement of heroin seeking in rats.
    Bossert JM; Wihbey KA; Pickens CL; Nair SG; Shaham Y
    Psychopharmacology (Berl); 2009 Sep; 206(1):51-60. PubMed ID: 19506837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats.
    Zhang Y; Kahng MW; Elkind JA; Weir VR; Hernandez NS; Stein LM; Schmidt HD
    Neuropsychopharmacology; 2020 Feb; 45(3):451-461. PubMed ID: 31581176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents.
    Vallöf D; Kalafateli AL; Jerlhag E
    Psychoneuroendocrinology; 2019 May; 103():284-295. PubMed ID: 30771711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA.
    Hernandez NS; Weir VR; Ragnini K; Merkel R; Zhang Y; Mace K; Rich MT; Christopher Pierce R; Schmidt HD
    Mol Psychiatry; 2021 Aug; 26(8):4394-4408. PubMed ID: 33257815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute glucagon-like peptide-1 receptor agonist liraglutide prevents cue-, stress-, and drug-induced heroin-seeking in rats.
    Douton JE; Acharya NK; Stoltzfus B; Sun D; Grigson PS; Nyland JE
    Behav Pharmacol; 2022 Aug; 33(5):364-378. PubMed ID: 35695511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Site-Specific Inhibitory Effects of the GLP-1 Analogue Exendin-4 on Alcohol Intake and Operant Responding for Palatable Food.
    Colvin KJ; Killen HS; Kanter MJ; Halperin MC; Engel L; Currie PJ
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of glucagon-like peptide-1 receptors and skilled reach foraging.
    Vestlund J; Bergquist F; Licheri V; Adermark L; Jerlhag E
    Addict Biol; 2021 May; 26(3):e12953. PubMed ID: 32770792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL/6J mice.
    Díaz-Megido C; Thomsen M
    Psychopharmacology (Berl); 2023 Jun; 240(6):1287-1298. PubMed ID: 37106129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
    Bornebusch AB; Fink-Jensen A; Wörtwein G; Seeley RJ; Thomsen M
    eNeuro; 2019; 6(2):. PubMed ID: 31058214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.